Related Experiment Video
Updated: Aug 18, 2026

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
Gorham-Stout disease with life-threatening pleural effusion treated with a pleuro-peritoneal shunt: a case report
Leevi A Toivonen1, Marko H Neva1, Thanos Sioris2
1Department of Orthopaedic and Trauma Surgery, Department of Internal Medicine.
Insights
Gorham-Stout disease (GSD) management can be improved with a multidisciplinary approach. A mini-invasive pleuro-peritoneal shunt effectively treated life-threatening pleural effusion in a GSD patient.
Area of Science:
- Orthopedics
- Rare Diseases
- Oncology
Background:
- Gorham-Stout disease (GSD) is a rare, aggressive bone disorder with unknown etiology.
- Massive osteolysis and lymphatic proliferation characterize GSD.
- Thoracic GSD can lead to life-threatening pleural effusion and neurological complications like paraparesis.
Purpose of the Study:
- To report a case of thoracic Gorham-Stout disease with paraparesis and severe pleural effusion.
- To highlight the successful management of pleural effusion using a pleuro-peritoneal shunt, a novel approach for GSD.
- To investigate the potential role of interleukin-6 and bone resorption markers in monitoring GSD activity.
Main Methods:
- Case report of a 23-year-old male with thoracic GSD.
- Management involved a multidisciplinary team approach.
- Treatment for pleural effusion utilized a mini-invasive pleuro-peritoneal shunt.
Main Results:
- The patient experienced a good recovery following multidisciplinary management.
- Pleuro-peritoneal shunting successfully resolved the life-threatening pleural effusion.
- Interleukin-6 and bone resorption markers showed potential utility in assessing disease activity.
Conclusions:
- A multidisciplinary approach is crucial for managing complex cases of Gorham-Stout disease.
- Pleuro-peritoneal shunting offers a viable, minimally invasive option for GSD-related pleural effusion.
- Biomarkers like IL-6 and bone resorption markers may aid in GSD activity monitoring.
Summary:
Gorham-Stout disease (GSD) is a rare bone disease characterized by massive osteolysis and lymphatic proliferation. The origin of the condition is unknown, and no established treatment protocol exists. Massive pleural effusion is a frequent complication of GSD in the thoracic region. We present the case of a 23-year-old male with thoracic GSD, subsequent paraparesis, and life-threatening pleural effusion. The patient was managed by a multidisciplinary team with a good recovery. The pleural effusion was successfully treated with a pleuro-peritoneal shunt. This is the first report of the use of this mini-invasive technique in the management of pleural effusion related to GSD. Further, we present the potential role of interleukin-6 and bone resorption markers in the measurement of the disease activity.
Learning Points:
Multidisciplinary approach is important in the management of rare and severe disorders such as Gorham-Stout disease. Pleuro-peritoneal shunting is a valuable option in the treatment of pleural effusion related to GSD. Interleukin-6 and bone resorption markers appear useful in measuring the disease activity of GSD.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II
Clinical Manifestations:
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:

